No heart safety issues seen with Merck Januvia diabetes drug: study

(Reuters) - Details of a large heart safety study presented on Monday appear to give Merck and Co's diabetes drug Januvia a clean bill of health, possibly setting the stage for a return to sales growth for the drugmaker's biggest product.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news